Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Clinical trial NCT06580223 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06580223
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma Venous Thromboembolism

Start date: 2025-09-01
Primary completion: 2027-09-01
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.